| (SC1) |
Applying Next Generation Sequencing Technologies to Research |
| (SC2) |
One Case Study in Breast Cancer-Three Perspectives |
| (SC3) |
Mighty Mitochondria: Their Relevance to Disease and Translational Medicine |
| (SC4) |
Addressing Safety Concerns for Biological Drugs |
| (SC5) |
Targeting Cancer Stem Cells with Biologics |
| (SC6) |
Dealing with the Blood-Brain Barrier |
| (SC7) |
Best Practices in Translational & Personalized Medicine |
| (SC8) |
Strategies for Molecular Diagnostic Companies |
| (SC9) |
Fragment-Inspired Medicinal Chemistry |
| (SC10) |
TransSporter-Mediated Drug-Drug Interaction Potential: Strategies for In Vitro Characterization |
| (SC11) |
Basic Immersion in Cutting Edge Science and Technology for Biotech and Pharma |
| (SC12) |
Designing Rigorous Omics Studies for Biomarker Discovery and Development of Prognostic and Predictive Molecular Diagnostics |
 Basic Immersion:
Cutting Edge Science & Technology for Biotech & Pharma
Download Brochure | Register Today
This short course is geared for the non-scientist. It highlights the basic science of recombinant DNA used in drug discovery and the basic science of how biologics are produced in drug development. Participants will walk away with a clear understanding of the difference between a biologic and the more traditional small molecule drugs historically made by the pharmaceutical industry.
 Strategic Review of Healthcare Information Technology
Smarter Studies: Designing Rigorous Omics
Semantic Technologies Brief
New Directions for Personalized Medicine
Future of Cancer Diagnostics
Impact of DNA Microarrays on Molecular Diagnostics
More White Papers
|
.jpg?n=736 "MMTC 2010 header") 
 
 The 2010 event was a huge success with over 2700 attendees across 38 countries, 1223 participating companies, 130 exhibitors and 44 sponsors.
Attendees enjoyed the ability to network with their peers, attend 11 concurrent programs within 6 scientific channels, and view the latest technologies.
Highlights included:
- John Crowley’s inspirational keynote “When Drug Research is Personal”. He shared his insight and families experiences and how research has been critical to the lives of his two children. John Crowley, is the inspiration for the motion picture Extraordinary Measures which is in theatres now!
- Interactive Break-Out Discussions and Roundtables
- New Product Pavilion – a complete resource center for new products displayed on the Exhibit Hall floor.
 
 Friday, October 23, 2009trong>
"Extraordinary Measures" - Hollywood Features the John Crowley Story
John Crowley, a featured keynote at this year's Molecular Medicine Tri-Conference, is the inspiration for a new film which will find its way onto the big screen January 22.
Go To Blog
  Answers to your questions about iPS Cells and ES Cells in this sneak PREVIEW of topics to be discussed at Stem Cells: Shaping the Future of Regenerative Medicine
Listen to a preview of Dr. Bruce Conklin's presentation on iPS Cells for Cadiovascular Models and Diagnostics on this just released podcast.
Click here to download
|